Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 1.633% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. COc1ccc(CCNC(=O)c2cc(-c3cc(Cl)ccc3O)n[nH]2)cc1OC
b. Cc1c(NC(=O)c2cccnc2C(=O)O)cccc1C(=O)O
Answer: b. Cc1c(NC(=O)c2cccnc2C(=O)O)cccc1C(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(NC(=O)c2cccnc2C(=O)O)cccc1C(=O)O
Cc1c(NC(=O)c2cccnc2C(=O)O)cccc1C(=O)O
3-[(3-carboxy-2-methylphenyl)carbamoyl]pyridine-2-carboxylic acid